2022 Policy Summit | September 26-27

Learn More

August 12: The ABCs of Starting Your Own Company

This month, we'll hear from one of the winners of ASGCT's 2022 Outstanding New Investigator Award, Matthew Hirsch, PhD, who will share his thoughts on diverse approaches to AAV biotech companies.

More Opportunities

Sept. 21-23: ASGCT-ISSCR Regenerative Medicine Symposium

ASGCT & ISSCR are partnering to host Emerging Therapies at the Intersection of Genetic and Cellular Technologies. ASGCT Members are eligible for discounted rates for this hybrid meeting!

Oct. 5: Novel CAR-T Cell Therapies for Malignancies

Join us for our next Insight Series session on October 5! More information to come.

Meeting, Workshop, & Course Information

ASGCT Annual Meetings

The annual meeting provides a forum for professionals to present and critically discuss the latest gene and cell therapy developments.

Professional Development Cafés

Our monthly professional development cafés are free live and on demand for ASGCT members.  

Pre-Meeting Workshops

Learn more about the ASGCT Pre-Meeting Workshops, traditionally held the day before the ASGCT Annual Meeting.


We've partnered with the National Organization for Rare Disorders to create a series of digital events designed to educate both patient and clinical audiences about the potential of gene therapy.

Non-ASGCT Events

Find out about other gene and cell therapy events throughout the year. 

ASGCT Discrimination & Harassment Policy

The fields of gene and cell therapy will be strongest when all members are supported by positive, safe, and healthy work environments. Our hope is that this policy will prevent incidents of harassment and discrimination, remove barriers to reporting incidents, and maintain the high quality of scientific discourse that we have come to expect at ASGCT events.


ASGCT Policy Summit

September 26-27, 2022

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.